Aj Wealth Strategies, LLC Verastem, Inc. Transaction History

Aj Wealth Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 19, 2019	SELL	$1.25 - $3.14 $140,221 - $352,235	-112,177 Reduced 76.65%	34,166 $52,000
Q1 2019 May 13, 2019	SELL	$2.79 - $4.09 $159,016 - $233,109	-56,995 Reduced 28.03%	146,343 $433,000
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $3,685 - $7,998	1,141 Added 0.56%	203,338 $683,000
Q3 2018 Nov 15, 2018	BUY	$6.86 - $9.97 $74,849 - $108,782	10,911 Added 5.7%	202,197 $1.47 Million
Q2 2018 Jul 19, 2018	SELL	$2.88 - $8.67 $12,188 - $36,691	-4,232 Reduced 2.16%	191,286 $1.32 Million
Q1 2018 Jul 19, 2018	BUY	$2.92 - $3.81 $28,271 - $36,888	9,682 Added 5.21%	195,518 $583,000
Q4 2017 Jul 19, 2018	BUY	$2.99 - $4.85 $459,996 - $746,148	153,845 Added 480.9%	185,836 $571,000
Q3 2017 Jul 19, 2018	SELL	$3.01 - $5.41 $53,776 - $96,655	-17,866 Reduced 35.83%	31,991 $150,000
Q2 2017 Jul 19, 2018	BUY	N/A	49,857	49,857 $109,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.37B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Aj Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Aj Wealth Strategies, LLC with notifications on news.